A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy.

Finbar Slevin,Sree Lakshmi Rodda,Peter Bownes,Louise Murray,David Bottomley, Clare Wilkinson,Ese Adiotomre,Bashar Al-Qaisieh,Emma Dugdale,Oliver Hulson,Joshua Mason,Jonathan Smith,Ann M Henry

Clinical and Translational Radiation Oncology（2020）

引用 15|浏览21

暂无评分

摘要

•Superior biochemical progression free survival for LDR in combination with EBRT.•On multivariable analysis, HDR and EBRT and Gleason ≥8 predicted for progression.•Low cumulative incidence of ≥grade 3 GU and GI toxicities.

查看译文

关键词

Prostate cancer,Low dose rate brachytherapy,High dose rate brachytherapy,External beam radiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要